LIVN News and Press, LivaNova PLC From 09/20/23

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2023 results on Wednesday, November 1, 2023 at 12 p.m. London time (8 a.m. Eastern Time). The Company will release its third-quarter 2023 results prior to the call. ...

2023-09-11 18:15:12 ET Summary Greenlight Capital's 13F portfolio value increased by 16% to $2.13B in Q2 2023. New stakes include Net Power Inc., Activision Blizzard, First Horizon Corp, and Seadrill Ltd. Stake disposals include Global Payments and Civitas Resources, while sta...

2023-09-10 15:17:31 ET HSBC initiated coverage of 11 US biopharma stocks this week, adding IQVIA, Zoetis, bluebird and Actinium Pharmaceuticals to its “buy” ratings list. IQVIA ( NYSE: IQV ) and Zoetis ( NYSE: ZTS ) were labeled “quality growthȁ...

2023-09-04 12:00:00 ET More on AI Cathie Wood's 'Big Ideas 2023' sees Artificial Intelligence as the future Artificial intelligence is a '1995 moment' for tech. That could push stocks even higher Apple CEO Tim Cook says artificial intelligence 'is a major focus of ou...

2023-08-31 08:59:49 ET More on LivaNova LivaNova: Struggling To Eye Value At Current Multiples, Reiterate Hold LivaNova PLC ( LIVN ) Q2 2023 Earnings Call Transcript LivaNova PLC 2023 Q2 - Results - Earnings Call Presentation LivaNova PLC beats Q2 top and...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM) , which provides accurate and continuous measurement of essential bloo...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Chair of LivaNova, will present in a fireside chat at the Baird Global Healthcare Conference in New York. The presentation will take place at 12:50 p.m. E...

2023-08-02 02:19:06 ET Summary LivaNova PLC posted mixed Q2 FY'23 results, with growth observed in the P&L and balance sheet. The company's Q2 earnings showed top-line growth and margin decompression on an adjusted basis. Despite this, I'm yet to be convinced based on the ...

2023-07-26 13:10:20 ET LivaNova PLC (LIVN) Q2 2023 Earnings Conference Call July 26, 2023, 08:00 ET Company Participants Matthew Dodds - SVP, Corporate Development & IT William Kozy - Chairman & Interim CEO Alex Shvartsburg - CFO Stephanie Bolton - Pr...

2023-07-26 06:10:09 ET LivaNova PLC press release ( NASDAQ: LIVN ): Q2 Non-GAAP EPS of $0.78 beats by $0.24 . Revenue of $293.9M (+15.6% Y/Y) beats by $28.86M . Full-Year 2023 Guidance: LivaNova now expects revenue for full-year 2023 to grow between 8% an...